PrEP support for trans women in New Orleans
Part of Immune system & allergy, Infections clinical trials.
This study aims to help more trans women (and other women who were assigned male at birth) use or restart PrEP, a medication that helps prevent HIV. You may be eligible if you are HIV-uninfected, live in the New Orleans area, and can do regular follow-up visits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older and sign an informed consent form
- Be HIV-uninfected (study will confirm this with testing)
- Be assigned male at birth, and identify as a trans woman or another gender not associated with being a man
- Want to start or restart PrEP
- Speak English or Spanish and live in the New Orleans area (8 parishes)
- Be willing to attend check-ins every 3 months and complete study surveys
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps transgender women who are not regularly using PrEP (a daily pill to prevent HIV) get access to HIV prevention services. It uses a smartphone to take pictures and connect with support.
This study is for cis-gender men who are HIV-negative and at risk for HIV. It tests a program to help you start and stay on PrEP (medication to prevent HIV).
This study helps connect young people aged 13–24 to PrEP, a daily pill that prevents HIV. It tests whether offering PrEP in clinics or community locations makes it easier for you to get and stay on this prevention medication.
This study is creating a decision-making tool to help transgender women choose the right PrEP (HIV prevention pill) for them. It is looking for transgender women in Denver who are HIV-negative and interested in learning more about PrEP, as well as healthcare providers who help transgender women decide about PrEP.
This study looks at how well long-acting injectable PrEP (a shot that prevents HIV) works for people who are at risk for HIV. Researchers want to understand the experience of patients and the healthcare staff who support them.
This study tests whether a program combining counseling and support can help more Black men in New York City get tested for HIV and start using PrEP or PEP (medicines that prevent HIV). If you are a Black man who has sex with men and are not living with HIV, this trial may be a good fit.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.